The signal
day one, before the first advisor was named or the first dollar raised.
The challenge
a brand-new company with a moonshot mission needed its first advisors and its first round of capital.
The Supernova advantage
exited founders building together from day one, which brought the right advisors and investors to the table faster.
The impact
with Colossal from seed through a $10.2B valuation and $600M+ raised.
Seed to decacorn · Biotech · Founding advisor plus exited-founder placements
Seed to decacorn in under four years.
Ben Lamm had built and exited companies before. He wanted to bring in the world's best to bring his mission to fruition.
Supernova started with Colossal at seed. It was our first portfolio company. Barry Stamos joined as founding advisor, recruited Peter Diamandis to the advisory board, and introduced investors who joined the first round.
Peter has since co-founded NeoGenesis Capital, a $200M venture fund built to back Colossal and the companies that grow out of its platform. That is what can happen when exited founders build together.
"They advise me. I advise others. That's the Supernova effect! When exited founders team up results happen faster."
Ben Lamm
CEO and Co-founder, Colossal Biosciences
With Colossal since seed · Decacorn within four years · Supernova's first portfolio company · Peter Diamandis placed on the advisory board · NeoGenesis Capital launched October 2026 to back the Colossal platform